Subcutaneous Tumors
Bayer starts phase I clinical trials of personalized vaccines in plants download snuff in the development of a patient specific vaccine represents a milestone for Bayer Innovation GmbH. Following approval of Phase I of the study by the FDA (Food & Drug Administration) in the United States, the vaccine is now being tested in humans. This is the first time that the proteins derived from plants using snuff magnICON ® technology to undergo clinical trials …
Tiny grenades deliver drugs by detonation
